BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND MSI2, ENSG00000153944, 124540
10 results:

  • 1. Clonal evolution dissection reveals that a high msi2 level promotes chemoresistance in T-cell acute lymphoblastic leukemia.
    Zhang J; Duan Y; Wu P; Chang Y; Wang Y; Hu T; Liu C; Chen X; Zong S; Chen X; Wu Y; Jin L; Lan Y; Liu X; Cheng X; Ding F; Li T; Chen X; Guo Y; Chen Y; Yang W; Zhang L; Zou Y; Cheng T; Zhu X; Zhang Y
    Blood; 2024 Jan; 143(4):320-335. PubMed ID: 37801708
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Down-regulation of Musashi-2 exerts antileukemic effects on acute lymphoblastic leukemia cells and increases sensitivity to dexamethasone.
    Zou D; Lv M; Chen Y; Niu T; Ma C; Shi C; Huang Z; Wu Y; Yang S; Wang Y; Wu N; Zhang Y; Ouyang G; Mu Q
    Ann Hematol; 2024 Jan; 103(1):141-151. PubMed ID: 37749318
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Transcriptome sequencing identifies novel EVX fusions involved in transcriptional activation of HOX family genes in pediatric immature T-cell acute lymphoblastic leukemia: two cases reports and a literature review.
    Zhang X; Cui B; Li Y; Li Z; Zheng J; Chu X; Xiao P; Lu J; Wang Z; Cen J; Liu Y; Hu S
    Int J Hematol; 2023 Oct; 118(4):508-513. PubMed ID: 37243888
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma.
    Erazo T; Evans CM; Zakheim D; Chu KL; Refermat AY; Asgari Z; Yang X; Da Silva Ferreira M; Mehta S; Russo MV; Knezevic A; Zhang XP; Chen Z; Fennell M; Garippa R; Seshan V; de Stanchina E; Barbash O; Batlevi CL; Leslie CS; Melnick AM; Younes A; Kharas MG
    Nat Commun; 2022 Sep; 13(1):5676. PubMed ID: 36167829
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Emerging roles of the long non-coding RNA 01296/microRNA-143-3p/msi2 axis in development of thyroid cancer.
    Wang ZL; Wang C; Liu W; Ai ZL
    Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693087
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Anticancer effect of quinacrine on diffuse large B‑cell lymphoma via inhibition of msi2‑NUMB signaling pathway.
    Yang S; Sheng L; Xu K; Wang Y; Zhu H; Zhang P; Mu Q; Ouyang G
    Mol Med Rep; 2018 Jan; 17(1):522-530. PubMed ID: 29115587
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prognostic significance of the Musashi-2 (msi2) gene in childhood acute lymphoblastic leukemia.
    Zhao HZ; Jia M; Luo ZB; Cheng YP; Xu XJ; Zhang JY; Li SS; Tang YM
    Neoplasma; 2016; 63(1):150-7. PubMed ID: 26639245
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Up-regulated msi2 is associated with more aggressive chronic myeloid leukemia.
    Kaeda J; Ringel F; Oberender C; Mills K; Quintarelli C; Pane F; Koschmieder S; Slany R; Schwarzer R; Saglio G; Hemmati P; van Lessen A; Amini L; Gresse M; Vagge E; Burmeister T; Serra A; Carson A; Schwarz M; Westermann J; Jundt F; Dörken B; le Coutre P
    Leuk Lymphoma; 2015 Jul; 56(7):2105-13. PubMed ID: 25363400
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognostic significance of msi2 predicts unfavorable outcome in adult B-acute lymphoblastic leukemia.
    Aly RM; Ghazy HF
    Int J Lab Hematol; 2015 Apr; 37(2):272-8. PubMed ID: 25090928
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. High expression of Musashi-2 indicates poor prognosis in adult B-cell acute lymphoblastic leukemia.
    Mu Q; Wang Y; Chen B; Qian W; Meng H; Tong H; Chen F; Ma Q; Ni W; Chen S; Jin J
    Leuk Res; 2013 Aug; 37(8):922-7. PubMed ID: 23759245
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.